What they were paid
Amneal Pharmaceuticals Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $127,500 | $250,000 | $0 | $36,412 | $413,912 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Amneal Pharmaceuticals, Inc. DEF 14A filed March 25, 2026, accession 0001308179-26-000143, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Amneal Pharmaceuticals pays directors a $75,000 cash retainer and $100,000 in equity.
Committees
FY2025 · as the proxy prints themCompensation · Conflicts
The rest of the Amneal Pharmaceuticals board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Chintu Patel | Director | $0 |
| Chirag Patel | Director | $0 |
| Deb Autor | Independent Director | — |
| Gautam Patel | Independent Director | $363,605 |
| J. Kevin Buchi | Independent Director | $393,333 |
| John Kiely | Independent Director | $434,594 |
| Paul Meister | Chair of the Board | $472,628 |
| Shlomo Yanai | Independent Director | $386,587 |
| Ted Nark | Independent Director | $401,025 |
The full Amneal Pharmaceuticals compensation record
free company briefThis page is one director within Amneal Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat